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422Objective: Forces acting on mitral annular devices in the setting of ischemic mitral regurgitation are currently
unknown. The aim of this study was to quantify the cyclic forces that result from mitral annular contraction in
a chronic ischemic mitral regurgitation ovine model and compare them with forces measured previously in
healthy animals.
Methods: A novel force transducer was implanted in the mitral annulus of 6 ovine subjects 8 weeks after an
inferior left ventricle infarction that produced progressive, severe chronic ischemic mitral regurgitation.
Septal–lateral and transverse forces were measured continuously for cardiac cycles reaching a peak left ventric-
ular pressure of 90, 125, 150, 175, and 200 mm Hg. Cyclic forces and their rate of change during isovolumetric
contraction were quantified and compared with those measured in healthy animals.
Results: Animals with chronic ischemic mitral regurgitation exhibited a mean mitral regurgitation grade of 2.3
 0.5. Ischemic mitral regurgitation was observed to decrease significantly septal–lateral forces at each level of
left ventricular pressure (P<.01). Transverse forces were consistently lower in the ischemic mitral regurgitation
group despite not reaching statistical significance. The rate of change of these forces during isovolumetric
contraction was found to increase significantly with peak left ventricular pressure (P<.005), but did not differ
significantly between animal groups.
Conclusions: Mitral annular forces were measured for the first time in a chronic ischemic mitral regurgitation
animal model. Our findings demonstrated an inferior left ventricular infarct to decrease significantly cyclic
septal–lateral forces while modestly lowering those in the transverse. The measurement of these forces and their
variation with left ventricular pressure contributes significantly to the development of mitral annular ischemic
mitral regurgitation devices. (J Thorac Cardiovasc Surg 2013;146:422-8)During the past decade, the surgical correction of ischemic
mitral regurgitation (IMR) has relied on undersized mitral
annuloplasty and mitral valve replacement.1-3 Their use,
however, has been challenged by the growing number of
patients who are elderly or who present with significant
comorbidities deemed too high risk for these
procedures.4-7 This trend, paired with an increasing desire
for less invasive approaches, has led to the developmenthe Wallace H. Coulter Department of Biomedical Engineering,a Georgia
te of Technology and Emory University, Atlanta, Ga; the Gorman Cardiovas-
Research Group,b University of Pennsylvania, Glenolden, Pa; the School of
ed Physiology,c Georgia Institute of Technology, Atlanta, Ga; and the
ion of Cardiovascular Devices,d Food and Drug Administration, Silver
g, Md.
dy was supported by a research grant awarded from the Food and Drug Ad-
tration (FDA1061718) and by grants from the National Heart, Lung and
Institute of the National Institutes of Health, Bethesda, Md. (HL63954
L73021). Dr Gorman and Dr Gorman were supported by individual Estab-
Investigator Awards from the American Heart Association, Dallas, Tex.
res: Authors have nothing to disclose with regard to commercial support.
d for publication Aug 16, 2012; revisions received Sept 14, 2012; accepted for
ation Oct 2, 2012; available ahead of print Oct 29, 2012.
for reprints: Ajit P. Yoganathan, PhD, 313 Ferst Drive, Atlanta, GA 30332
il: ajit.yoganathan@bme.gatech.edu).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.10.006
The Journal of Thoracic and Cardiovascular Surgof minimally invasive and percutaneous surgery for IMR.
Although these techniques exhibit potential for treating
a large number of patients, many challenges remain in
demonstrating equivalent or improved clinical therapeutic
benefits compared with optimally performed mitral
annuloplasty or valve replacement.6-8
A key to demonstrating equivalent or improved clinical
therapeutic benefits is the development of minimally inva-
sive devices that not only facilitate delivery but reduce
IMR. Although reductions in mitral regurgitation (MR)
have been shown in preclinical studies, concerns have
been raised regarding the safety of these devices.5-9 In
specific, these devices are structurally smaller, more
flexible, and may be less durable than comparably rigid
replacement valves or rigid undersized complete
annuloplasty rings. As a result, these devices may
experience greater structural deformations and as such
may be more prone to strain-related material failure.5,7,9
Despite their fundamental importance, limited knowl-
edge exists regarding the forces acting on devices
implanted in the mitral annulus.10-13 Isolated directions of
compressive force on mechanical and prosthetic mitral
valves have been measured and found to range from 6 to
8 N and from 4.4 to 13.9 N, respectively.10,11 Although ofery c August 2013
Abbreviations and Acronyms
dF/dt ¼ peak rate of change of force
d(LVP)/dt ¼ peak rate of change of LVP
IMR ¼ ischemic mitral regurgitation
LV ¼ left ventricular
LVP ¼ left ventricular pressure
MR ¼ mitral regurgitation
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influence of a saddled geometry on the distribution of
bending forces in simulated annuloplasty rings.12,13
Although groundbreaking, each of these studies was
limited to a healthy porcine model and was unable to
quantify the effects of ventricular or valvular disease on
measured forces. The directional variation and rate of
change of these forces for increasing ventricular afterload
are also unavailable.
Determining these unknowns are critical to the design
and evaluation of minimally invasive and transcatheter de-
vices. Because many of these devices are heterogeneous di-
rectionally, evaluating directional differences in force with
increasing ventricular afterload can inform worst-case load-
ing conditions. Determining the rate of change of these
forces during ventricular contraction will also inform de-
vice testing and the use of device materials with rate- or
time-dependent material properties. The ability to quantify
these end points in the presence of an inferior left ventricu-
lar infarction will contribute significantly to the develop-
ment of minimally invasive and percutaneous IMR
devices. To this end, we now describe the use of a novel
force transducer to measure the septal–lateral and trans-
verse forces that result from mitral annular contraction in
a chronic IMR ovine model at increasing levels of ventric-
ular afterload.METHODS
Mitral Annular Force Transducer
A novel transducer was developed to measure in-plane radial forces re-
sulting from mitral annular contraction.14,15 Pictured in Figure 1, this de-
vice has a D-shaped profile with a size that is constrained to mitral
annular dimensions measured previously in an identical chronic IMR
model.16 The transducer included 2 measurement arms oriented in the
septal–lateral and transverse directions of the mitral annulus. To facilitate
implantation, each measurement arm included lateral passages to secure
sutures between the annulus and the device. The development, fabrication,
calibration, accuracy, sensitivity, and use for the measurement of annular
forces in healthy ovine animals have been reported previously.14,15
Chronic IMR Animal Model
The animals used in this work received care in compliance with the pro-
tocols approved by the Institutional Animal Care and Use Committee at the
University of Pennsylvania in accordance with the guidelines for humane
care.17 Six ovine subjects received an inferior left ventricular infarction
to produce progressive, chronic IMR. This model has been studiedThe Journal of Thoracic and Caextensively and mimics precisely an inferior infarction described in hu-
mans.16,18-20 Through a sterile left lateral thoracotomy, snares were
placed to occlude permanently the proximal second and third obtuse
marginal branches of the circumflex coronary artery. After infarction, the
thoracotomy was closed and IMR allowed to progress for an 8-week period
prior to transducer implantation and annular force measurement.
Experimental Protocol
Six Dorsett Hybrid sheep (40.1  2.9 kg) were intubated, anesthetized,
and ventilated with isoflurane (1.5%-2%) and oxygen. Surface electrocar-
diogram and arterial blood pressure were monitored. A right thoracotomy
was performed. On the heart’s exposure, epicardial Doppler echocardio-
graphic images were obtained to evaluate MR at a peak left ventricular
pressure (LVP) of approximately 90mmHg (Phillips IE33Matrix; Phillips,
Amsterdam, The Netherlands). Mitral regurgitation was graded on a 0- to
4þ-scale, where 0 represents no MR and 4þ represents severe MRwith re-
versal of pulmonary vein flow. After establishment of cardiopulmonary by-
pass, a left atriotomy was performed. Eight 2-0 Ethibond Exel polyester
sutures (Ethicon, Piscataway, NJ) were passed through the mitral annulus
in positions relative to the lateral passages located on the annular force
transducer. These sutures were passed through the device and secured to
the mitral annulus as in mitral annuloplasty.14,15
Visual inspection was used to verify transducer placement and orienta-
tion in the mitral annulus. After separation from cardiopulmonary bypass,
a high-fidelity pressure transducer (SPR-3505; Millar Instruments, Hous-
ton, Tex) was passed percutaneously into the left ventricle through the fem-
oral artery for continuousmeasurement of LVP. Surface electrocardiogram,
LVP, and arterial pressure (Hewlett-Packard 78534C monitor; Hewlett-
Packard, Inc, Santa Clara, Calif) were monitored continuously. On estab-
lishing baseline hemodynamics (90 mm Hg peak LVP, 3.3 L/min cardiac
output), forces resulting from mitral annular contraction were measured
in the postcardioplegic heart.
To simulate worst-case loading scenarios, forces were recorded
throughout the cardiac cycle for increasing levels of peak LVP at 125,
150, 175, and 200 mm Hg. Elevated levels of LVP were achieved via intra-
venous injection of norepinephrine. After successful force measurement,
animals were euthanized with 1 g thiopental and 80 mEq KCl. Hearts
were removed and opened to verify secure anchoring of the device to the
mitral annulus and to measure the total infarct area with respect to the
left ventricular (LV) endocardium. This protocol was identical to that
used previously to measure mitral annular forces in healthy ovine
subjects.15
Data Acquisition
Mitral annular forces were acquired continuously using a compact Data
Acquisition System (cDAQ 9174) and a strain gauge bridge module
(NI 9237; National Instruments, Austin, Tex). Left ventricular pressure
was measured from the Millar pressure catheter’s control unit using an an-
alog voltage module (NI 9215; National Instruments). Forces and LVP
were monitored and recorded continuously using a customized LabVIEW
program (National Instruments) at 1613 Hz. This rate was sufficient for
force measurement as well as for the determination of the rate increase
of force during isovolumetric contraction.14,15
Data and Statistical Analysis
All acquired data were processed offline using a custom Matlab pro-
gram (Mathworks, Natick, Mass). Forces are reported as the change from
their minimum diastolic value to maximum systolic value. The peak rate
of change of LVP (d(LVP)/dt) and force (dF/dt) with time during isovolu-
metric contraction were also determined. Peak values measured in each an-
imal were averaged over 10 consecutive cardiac cycles and averaged
subsequently in each animal group and level of afterload. All results are
reported as a mean  1 standard deviation.rdiovascular Surgery c Volume 146, Number 2 423
FIGURE 1. Developed mitral annular force transducer with measurement
directions and features identified. (A) One-millimeter-diameter suture pas-
sages placed in 4-mm increments from the centerline of each measurement
arm for transducer–annulus anchoring. (B) Strain gauge to measure septal–
lateral force. (C) Strain gauge to measure transverse force. (D) Transducer
spring element. (E) Exit wire harness. (F) Posterior mitral leaflet. (G) An-
terior mitral leaflet. (H) Mitral annulus.
TABLE 2. Characteristics of the ovine subjects at elevated levels of left
ventricular pressure
Parameter and
animal group
Target peak left ventricular pressure, mm Hg
90 125 150 175 200
Peak left ventricular
pressure, mm Hg
Control 90  2 128  3 151  3 173  3 201  4
Chronic IMR 92  2 124  2 152  2 177  2 198  4
Heart rate, beats/min
Control 95  15 116  33 127  32 140  38 142  35
Chronic IMR 96  9 111  11 117  16 130  22 143  18
IMR, Ischemic mitral regurgitation.
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tively with those measured and reported previously in a healthy ovine
model.15 Mean measured forces and rates of force with time were checked
for normality using the Anderson-Darling test. Changes in force and dF/dt
with increasing levels of afterload in both the control and chronic IMR
group were tested using repeated-measures analysis of variance. If a signif-
icant effect was revealed, a Dunnett post hoc test was used to determine
whether forces measured at elevated levels of LVPwere greater statistically
than those measured at baseline conditions. To determine whether differ-
ences in force and dF/dt exist between each group, between-groups re-
peated-measures analysis of variance was conducted. If a significant
difference was revealed, a conservative Bonferroni post hoc test was
used to determine at which levels of ventricular afterload the differences
exist. All statistical tests were completed using Minitab 16 (Minitab, Inc,
State College, Pa).RESULTS
Baseline and Elevated Animal Characteristics
Baseline characteristics of the chronic IMR (n ¼ 6) and
control (n ¼ 6) animals are presented in Table 1.15 For
the chronic IMR animals, the mean MR grade measured 8
weeks after myocardial infarction was 2.3  0.5. Resulting
MR grades were comparable with those achieved in previ-
ous studies using an identical chronic IMR model.16,18,19
When simulating worst-case loading conditions, LVP was
controlled carefully in each animal. No statistical differ-
ences were observed between animal groups for measured
levels of elevated LVP and heart rate (Table 2). DuringTABLE 1. Baseline characteristics of the ovine subjects
Parameter
Control animals
(n ¼ 6)
Chronic IMR animals
(n ¼ 6)
Weight, kg 40.1  7.4 39.7  2.6
Heart rate, beats/min 95  15 96  9
LVP, mm Hg 90  2 92  2
d(LVP)/dt, mm Hg/sec 2105  712 1253  307
Graded MR 0 2.3  0.5
Infarcted endocardium,% 0 19.0  1.7
IMR, Ischemic mitral regurgitation; LVP, left ventricular pressure; d(LVP)/dt, peak
rate of change of LVP; MR, mitral regurgitation.
424 The Journal of Thoracic and Cardiovascular Surgeach study, real-time 3-dimensional echocardiographic im-
ages were acquired to assess transducer anchoring through-
out the experiment. During all experiments, the transducer
remained secured firmly to the mitral annulus.Change in Force Throughout the Cardiac Cycle
Among control and chronic IMR animals, forces in the
septal–lateral and transverse directions were observed to in-
crease compressively from ventricular diastole to mid sys-
tole. Representative unfiltered forces from both a control
and chronic IMR animal are plotted with time and LVP in
Figure 2. In both animals, slight elevations in force are
seen during atrial systole followed by sharp increases dur-
ing isovolumetric contraction. During this period, septal–
lateral and transverse forces were found to increase with
LVP (P<.001) and peak at approximately mid systole.Change in Force With Increasing Afterload: Chronic
IMR Animals
Septal–lateral force in the chronic IMR animals was
found to differ statistically between increasing levels ofFIGURE 2. Representative unfiltered forces from both a control animal
(A) and chronic IMR animal (B) are plotted with time and left ventricular
pressure. IMR, Ischemic mitral regurgitation.
ery c August 2013
FIGURE 3. (A) The measured change in septal–lateral force throughout
the cardiac cycle was observed to to be significantly greater in the control
animals at each level of peak left ventricular pressure. (B) No significant
differences in the change in transverse force throughout the cardiac cycle
was observed between the animal groups and left ventricular pressure
levels. IMR, Ischemic mitral regurgitation. *P<.01. yP<.005.
TABLE 3. Peak rate of change of septal–lateral and transverse forces
during isovolumetric contraction for the control and chronic IMR
animals
Force direction and
animal group
Peak left ventricular pressure, mm Hg
90 125 150 175 200
Septal–lateral
dF/dt, N/sec
Control 77  31 126  48 150  72* 169  89y 180  95z
Chronic IMR 39  12 42  6 64  9y 66  7z 74  12z
Transverse
dF/dt, N/sec
Control 36  16 70  32 88  42y 85  43* 72  48
Chronic IMR 30  18 40  19 60  17y 68  35z 62  26y
dF/dt, Peak rate of change of force; IMR, ischemic mitral regurgitation. Signficance is
reported for the baseline values at 90 mm Hg peak left ventricular pressure in each
group and direction. *P<.01. yP<.005. zP<.001.
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from the baseline of 2.5  0.6 N to 3.5  0.7 N at 150 mm
Hg (P<.001), 3.7 0.6 N at 175mmHg (P<.001), and 3.7
 0.8 N at 200mmHg (P<.001). No significant differences
were found between the baseline and 2.9 0.6 N at 125mm
Hg peak LVP. The peak septal–lateral force measured
among all chronic IMR animals was 4.5 N at 200 mm Hg
peak LVP.
The change in transverse forces throughout the cardiac
cycle were also found to differ statistically with afterload
(P < .05). Transverse forces were observed to increase
from the baseline of 2.2  0.9 N to 2.9  0.9 N at 150
mm Hg (P< .05) and 2.9  1.2 N at 175 mm Hg (P<
.05). Transverse forces measured at 125 mm Hg (2.7 
0.8 N) and 200 mm Hg (2.7  1.2 N) were found to be
not statistically different from the baseline measurement.
The peak transverse force measured in the chronic IMR an-
imals was 4.6 N at 175 mm Hg peak LVP. To determine
whether directional differences exist, septal–lateral and
transverse forces were compared at each level of peak
LVP. No statistical differences were observed between these
directions in the chronic IMR animals.
Change in Force for Increasing Afterload: Control
Versus Chronic IMR Animals
To determine whether an inferior LV infarction results in
a decrease in mitral annular forces, chronic IMR forces
were compared with those measured previously in a healthy
ovine model.15 Among all animals, the mean change in sep-
tal–lateral force was found to differ statistically between
increasing levels of afterload (P<.001) and animal groups
(P<.001). Septal–lateral forces in the control animals were
found to be significantly larger than those in the chronic
IMR group at 90 mm Hg (P< .01), 125 mm Hg (P<
.005), 150 mm Hg (P< .005), 175 mm Hg (P< .005),
and 200 mm Hg (P< .005). These results are plotted in
Figure 3.
Among all animals, the mean change in transverse force
was found to differ statistically between increasing levels of
afterload (P< .001) but not between animal groups. Al-
though nonsignificant, the mean transverse forces in the
chronic IMR group were observed to be consistently lower
in magnitude than those measured in control animals, as
shown in Figure 3.
Rate of Change of Force During Isovolumetric
Contraction: Control Versus Chronic IMR Animals
The peak rate increase of force during isovolumetric con-
traction was quantified for both the control and chronic IMR
animals at elevated levels of LVP. Among all animals, sep-
tal–lateral dF/dt was found to differ significantly between
increasing levels of peak LVP (P<.005) and animal groups
(P<.05). Within the control group, septal–lateral dF/dt was
found to increase significantly from the baseline conditionThe Journal of Thoracic and Cato 150 mm Hg (P<.01), 175 mm Hg (P<.005), and 200
mm Hg (P < .001; Table 3). No significant differences
were observed between the baseline and 125 mm Hg. In
the chronic IMR group, the peak septal–lateral dF/dt was
found to increase significantly from the baseline to 150
mm Hg (P<.005), 175 mm Hg (P<.001), and 200 mm
Hg (P<.001). Similar to the control group, no significant
differences were found between the baseline condition
and 125 mm Hg peak LVP. After adjusting for multiplerdiovascular Surgery c Volume 146, Number 2 425
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dt were found between the control and chronic IMR animal
groups at each level of LVP.
In the transverse direction, the peak dF/dt was found to
increase significantly with afterload in all animals (P<
.001), but did not differ significantly between groups
(Table 3). In the control group, transverse dF/dt was
found to increase significantly from the baseline to 150
mm Hg (P<.005) and 175 mm Hg (P<.01). In the chronic
IMR animals, transverse dF/dt was found to increase from
the baseline to a peak LVP of 150 mm Hg (P< .005),
175 mm Hg (P<.001), and 200 mm Hg (P<.005).
DISCUSSION
Ejection of the heart’s blood to the systemic circulation
requires the left ventricle to generate enough pressure to
open the aortic valve leaflets and empty the LV volume.
This critical function is accomplished by the myocardium
aligned helically in the LV wall. During ventricular systole,
the myocardium contracts and reduces the LV diameter by
generating forces that act along the direction of each myo-
cardial fiber. These forces not only facilitate the generation
of LVP, but at the basal level, reduce the mitral annular area
and compress devices implanted to the mitral annulus.14,15
The septal–lateral and transverse forces measured in this
study are vector components of the circumferentially
generated myocardial forces.
This study shows that an inferiorLVinfarctiondecreases sig-
nificantly septal–lateral forces while decreasing modestly
those in the transverse direction. This can be explained in
that an inferior infarction not only impairs the ability of the in-
farcted myocardium to contract, but also alters the cross-
sectional geometry of the left ventricle.16,18-21 As a result of
the infarction, the magnitudes of circumferentially directed
forces in the posteroinferior wall are reduced and are more
oblique directionally with respect to the geometric center of
the left ventricle. As a result, the relative contributions of the
posteroinferior myocardium to the radially directed septal–
lateral and transverse forces are reduced. We believe the
septal–lateral force was decreased to a greater extent because
of ligation of the obtuse marginal 3 coronary artery, which
has been shown previously to impair more of the posterior
wall.20
Lower observed forces in the chronic IMR animals have
important implications in the development of minimally in-
vasive and transcatheter IMR devices. These forces can in-
form bench and computational tests to evaluate the
structural durability and relevant failure modes of these de-
vices. International standards organization standards and
U.S. Food and Drug Administration (FDA) guidelines rec-
ommend evaluating these devices under cyclic forces at
magnitudes at least as severe as those anticipated
in vivo.22,23 Although septal–lateral and transverse forces
were observed to be reduced in the presence of IMR,426 The Journal of Thoracic and Cardiovascular Surga reasonable safety margin needs to be maintained to
ensure device durability and patient safety.5,6,24
Previous findings in healthy animals demonstrated direc-
tional differences in the change in force throughout the car-
diac cycle.15 These differences and their exacerbation with
increasing LVP can inform the structural strengthening of
devices and worst-case loading conditions. Despite these
previous findings, directional differences were not observed
in the chronic IMR animals. An inferior infarction was
found to decrease significantly the septal–lateral forces,
but not to a magnitude that was different statistically from
those measured in the transverse direction. Although trans-
verse forces were consistently lower in the chronic IMR
group, they were not different statistically from transverse
forces measured in healthy animals.
In addition to cyclic force magnitudes, the rates at which
these forces increase during ventricular contraction carry
equal importance. These rates can inform more accurately
device testing and the use of device materials (eg, polymers)
with rate-dependent behavior.22-24 This study was the first to
quantify these rates at elevated levels of peak LVP. The rates
measured were found to increase significantly with peak
LVP, but did not differ significantly between directions and
groups. Although statistically significant differences in dF/
dt were not observed between groups in the septal—lateral
direction, we believe the large differences in magnitude are
representative of a meaningful difference that might be
observed to be statistically significant with a larger sample
size. When combined with the peak magnitudes of these
cyclic forces, measured rates will contribute to more
accurate experimental and computational models that
assist further in optimizing device materials, design,
durability, and safety.
The translation of the measured chronic IMR annular
forces in the ovine model to what may be anticipated in pa-
tients with IMR requires careful attention. Healthy ovine an-
imals and humans have been compared previously and were
shown to have similar mitral annular areas, LV mass and
wall thickness, and comparable LVP and d(LVP)/dt.3,15
Ligation of the obtuse marginal coronaries infarcts
approximately 20% of the LV mass, includes the
posteromedial papillary muscle, and produces increasingly
more severe MR with progressive LV remodeling.16,18-20
Similar to clinical descriptions, abnormalities and
reductions in both LV and mitral valve contractility are
observed with significant increases in end systolic and
diastolic LV volumes.16,25,26 Although the size and age of
infarcts in patients with IMR vary widely, LV wall motion
abnormalities are overwhelmingly located in the
posteroinferior aspect of the left ventricle and usually
involve the posterior papillary muscle.21
Given that our forces were measured under anesthesia
and in the postcardioplegic heart, we believe mitral annular
forces in humans with a posterior infarct to be of greaterery c August 2013
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LVP. The forces expected in the human mitral annulus
may present greater directional heterogeneity because cor-
onary disease may be more widespread and may affect
global LV contraction. We hypothesize a greater degree of
localized myocardial infarction may result in a dispropor-
tionate systolic annular area reduction and potential shear-
ing of devices in the mitral annulus. Moreover, annular
undersizing, as seen in restrictive mitral annuloplasty,
may differ from the results we present because the ring is
likely to undergo cyclic tension from a contracting and
grossly dilated left ventricle. Future studies are required
to describe these force profiles and to understand the poten-
tial heterogeneity introduced by reshaping the mitral annu-
lus to a given device.
Limitations
Several limitations exist in the methods and results of this
study. Limitations resulting from device annular sizing, cal-
ibration, and limits of reporting absolute forces have been
described previously.15 In addition to these, the magnitude
of forces measured in the chronic IMR model is likely de-
pendent on infarct size and may change with a lesser or
greater degree of myocardial infarction. Described forces
are limited to this IMR model and may not represent the
forces that may be seen in other mitral etiologies. Because
IMR repairs aim to reshape and reduce mitral annular area,
transducers implanted in our chronic IMR animals were
sized to the enlarged mitral annulus. This was done to re-
duce any unknown effects of transducer–annular sizing on
measured forces. In each study, the transducers were found
to be either slightly undersized or exhibit a snug but not
oversized fit. Absolute forces experienced by each device
resulting from implantation and function were difficult to
quantify because of the observed variations in the diastolic
forces from combined changes in annular contractility. For
these reasons, the change in force throughout the cardiac cy-
cle is reported.
Because implantation of any device likely alters native
mitral annular mechanics, any forces measured may not
be equal to those in absence of the implanted device. Al-
though the areal reduction of the mitral annulus and myo-
cardial strain can be measured noninvasively, the
relationship between these quantities and annular force is
unknown. For these reasons, mitral annular forces must be
measured currently with an implanted device. Because all
studies were terminal, the long-term impact of these devices
on left heart function was not assessed.
CONCLUSIONS
Mitral annular forces were measured for the first time in
a chronic IMR animal model. Our findings demonstrate an
inferior LV infarct to result in significantly decreasing sep-
tal–lateral forces while lowering modestly those in theThe Journal of Thoracic and Catransverse. The rate of change of septal–lateral and trans-
verse forces during isovolumetric contraction were also
quantified and shown to increase significantly with peak
LVP. Using similar methods, parallel studies are currently
underway to evaluate repair techniques that reduce forces
acting on devices as well as those contributing to a tethering
subvalvular mitral valve geometry. Combined, these force
measurements will aid significantly in the development of
devices interacting with the mitral annulus, including those
implanted through minimally invasive and percutaneous
approaches.
We acknowledge the contributions to and development of the
data acquisition platform provided by members of the Cardiovas-
cular Research Unit in Arhus, Denmark.References
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